News Releases

Select year
Categories

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

Dec 14, 2021 | Corporate

Read more

Myriad Genetics Names Pamela Wong as Chief Legal Officer

Oct 18, 2021 | Corporate

Read more

Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing Business to LabCorp

Sep 13, 2021 | Corporate

Read more

Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities

Jul 21, 2021 | Corporate | Products

Read more

Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions

Jul 01, 2021 | Corporate

Read more

Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics

Jun 16, 2021 | Corporate

Read more

Myriad Genetics CEO Paul J. Diaz to Present at Goldman Sachs 2021 Virtual Global Healthcare Conference

Jun 04, 2021 | Corporate

Read more

Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences

Jun 01, 2021 | Corporate | Products

Read more

Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions

May 24, 2021 | Corporate | Financial

Read more

Myriad Genetics Appoints Melissa Gonzales to Lead Women’s Health Business

May 20, 2021 | Corporate

Read more

Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference

May 05, 2021 | Corporate

Read more

Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp

May 03, 2021 | Corporate

Read more

Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor Day

May 03, 2021 | Corporate

Read more

Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021

Apr 27, 2021 | Corporate

Read more

Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences

Apr 27, 2021 | Corporate

Read more

Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders

Mar 29, 2021 | Corporate

Read more

Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives

Feb 18, 2021 | Corporate

Read more

Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences

Feb 11, 2021 | Corporate

Read more

Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations

Jan 05, 2021 | Corporate

Read more

Myriad Genetics CEO Paul J. Diaz to Present at 39th Annual J.P. Morgan Healthcare Conference

Jan 04, 2021 | Corporate

Read more